<DOC>
	<DOCNO>NCT02899000</DOCNO>
	<brief_summary>Demonstrate daily treatment regimen adapalene 0.3 % /benzoyl peroxide 2.5 % gel + oral Doxycycline 200 mg effective safe severe inflammatory acne 3 few nodule cyst ( non-nodulocystic ) 12-week treatment period .</brief_summary>
	<brief_title>A Treatment Severe Inflammatory Acne Subjects</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Key 1 . Male female subject , 12 year age old Screening visit . 2 . Subjects clinical diagnosis severe inflammatory acne ( IGA score 4 ) . 3 . Subjects 4 few nodule cyst &gt; 1 cm diameter face . 4 . Subjects 18 year age old must read sign Informed Consent Form , include Photography Consent HIPAA authorization , prior participation study . Consent obtain prior studyrelated procedure . Subjects age 18 year must sign Assent Participate Form participate study must one parent guardian read sign Informed Consent Form prior studyrelated procedure . ( The parent guardian require attend follow visit unless request . ) Key 1 . Subjects nodulocystic conglobate acne , acne fulminans , secondary acne ( chloracne , druginduced acne , etc. ) . 2 . Subjects 5 acne nodule cyst &gt; 1 cm diameter face Screening Baseline visit . 3 . Female subject pregnant , nursing , plan pregnancy study . 4 . Subjects use systemic therapy direct improve acne , include antibiotic , within 30 day prior Baseline visit . 5 . Subjects risk term precaution , warning , contraindication investigational study drug ( see Appendix 14.1 package insert adapalene 0.3 % /benzoyl peroxide 2.5 % gel doxycycline hyclate Tablets ) . 6 . Subjects condition circumstance , Investigator 's opinion , may put subject risk ( e.g. , history significant renal disease impairment renal function ) , confound study result , interfere subject 's participation study . 7 . Sponsor study site staff , relatives staff member , individual would access clinical study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>